9:22 AM
Leo Group India
| ||
| Eisai and Arena Pharmaceuticals Complete Transfer of BELVIQ® (lorcaserin ... MarketWatch (press release) Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing innovative medicines that selectively target G protein-coupled receptors. Arena is committed to delivering novel treatment options to patients for ... See all stories on this topic » | ||
| Aeolus Pharmaceuticals Announces AEOL 10150 Diminishes Oxidative Stress ... MarketWatch (press release) MISSION VIEJO, CA, Jul 30, 2012 (MARKETWIRE via COMTEX) -- Aeolus Pharmaceuticals, Inc. (otcqb:AOLS) (OBB:AOLS) , a biotechnology company leveraging significant government funding to develop a platform of novel compounds in oncology and ... See all stories on this topic » | ||
| Tonix Pharmaceuticals Announces Completion of Clinical Trial of Sublingual ... MarketWatch (press release) NEW YORK, Jul 30, 2012 (BUSINESS WIRE) -- Tonix Pharmaceuticals Holding Corp. (OTN:TNXP) ("TONIX" or the "Company"), a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system ("CNS"), ... See all stories on this topic » | ||
| Sunovion Pharmaceuticals Inc. Announces Nationwide Availability of ZETONNA ... MarketWatch (press release) MARLBOROUGH, Mass., Jul 30, 2012 (BUSINESS WIRE) -- Sunovion Pharmaceuticals Inc. (Sunovion) today announced the nationwide availability of ZETONNA(TM) (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), ... See all stories on this topic » | ||
| Simcere Pharmaceutical Group to Announce Second Quarter 2012 Financial ... MarketWatch (press release) Simcere Pharmaceutical Group (NYSE:SCR) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China. Simcere concentrates its research and development ... See all stories on this topic » | ||
| Somaxon Pharmaceuticals to Report Second Quarter 2012 Results and Conduct ... MarketWatch (press release) SAN DIEGO, Jul 30, 2012 (GlobeNewswire via COMTEX) -- Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) , a specialty pharmaceutical company, today announced that it will release its second quarter financial results for the period ended June 30, 2012, ... See all stories on this topic » | ||
| US Hot Stocks: Diebold, Shaw Group, MWI Veterinary Supply Wall Street Journal (India) Acura Pharmaceuticals Inc. ($2.03, -$1.05, -34.09%) said Pfizer Inc. (PFE, $23.80, -$0.03, -0.10%) has terminated the license to three development-stage products using the specialty pharmaceutical company's tamper-resistant technology and will return the ... See all stories on this topic » | ||
| Amgen and Idenix Pharmaceuticals Showing Strong Growth -- Biotech Industry ... Investor's Business Daily NEW YORK, NY--(Marketwire - Jul 30, 2012) - The Biotechnology Industry has been soaring in 2012 as companies -- both large and small -- have shown impressive growth. The SPDR S&P Biotech ETF (XBI) and the First Trust NYSE Arca Biotech Index ETF ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment